{"created":"2023-05-15T11:13:42.965553+00:00","links":{},"metadata":{"_buckets":{"deposit":"95da9e08-2b8e-4875-9b91-11f0bac39db3"},"_deposit":{"id":"1532.1","owners":[2],"pid":{"revision_id":0,"type":"depid","value":"1532.1"},"status":"published"},"_oai":{"id":"oai:miyazaki-u.repo.nii.ac.jp:00001532.1","sets":["72:30"]},"author_link":["8019","9108","9109","9110","8383","9113","9114","9115"],"item_10001_biblio_info_7":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2009-11","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"12","bibliographicPageEnd":"2539","bibliographicPageStart":"2533","bibliographicVolumeNumber":"12","bibliographic_titles":[{"bibliographic_title":"臨床精神薬理","bibliographic_titleLang":"ja"},{"bibliographic_title":"Japanese journal of clinical psychopharmacology","bibliographic_titleLang":"en"}]}]},"item_10001_description_5":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"宮崎入学医学部附属病院精神科でrisperidone錠からrisperidone口腔内崩壊錠（risperidoneOD錠）に切り替えた患者38症例に,｢のみ心地｣などに関する無記名式アンケート調査を行い,服薬アドヒアランスおよび患者のQOLについて検討した｡対象はrisperidone錠を内服している患者群とし,疾患,年齢,性別,受療形態（入院･外来）は問わず,risperidoneOD錠に切り替えて4-8週後に各主治医が患者にアンケート調査を実施した｡患者38症例のうち統合失調症が7割を占め,risperidone単剤服用患者が約6割であった｡アンケートの結果,特に｢のみ心地｣｢利便性｣｢忙しい時でも服用できる｣｢携帯性｣｢服薬の手間｣｢服薬継続｣の質問に対して,risperidone OD錠を評価する傾向が認められた｡OD錠がrisperidoneの剤形に追加されたことで,薬物治療の継続において重要なアドヒアランスの向上に寄与する可能性が示唆された｡","subitem_description_language":"ja","subitem_description_type":"Abstract"}]},"item_10001_publisher_8":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"星和書店","subitem_publisher_language":"ja"}]},"item_10001_source_id_11":{"attribute_name":"書誌レコードID","attribute_value_mlt":[{"subitem_source_identifier":"AA11171463","subitem_source_identifier_type":"NCID"}]},"item_10001_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"13433474","subitem_source_identifier_type":"ISSN"}]},"item_10001_version_type_20":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"長友, 慶子","creatorNameLang":"ja"},{"creatorName":"ナガトモ, ケイコ","creatorNameLang":"ja-Kana"},{"creatorName":"Nagatomo, Keiko","creatorNameLang":"en"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"松尾, 寿栄","creatorNameLang":"ja"},{"creatorName":"マツオ, ヒサエ","creatorNameLang":"ja-Kana"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"石塚, 雄太","creatorNameLang":"ja"},{"creatorName":"イシヅカ, ユウタ","creatorNameLang":"ja-Kana"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"安部, 博史","creatorNameLang":"ja"},{"creatorName":"アベ, ヒロシ","creatorNameLang":"ja-Kana"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"石田, 康","creatorNameLang":"ja"},{"creatorName":"イシダ, ヤスシ","creatorNameLang":"ja-Kana"},{"creatorName":"Ishida, Yasushi","creatorNameLang":"en"}],"nameIdentifiers":[{},{}]},{"creatorNames":[{"creatorName":"Matsuo, Hisae","creatorNameLang":"en"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Ishizuka, Yuta","creatorNameLang":"en"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Abe, Hiroshi","creatorNameLang":"en"}],"nameIdentifiers":[{}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2020-06-21"}],"displaytype":"detail","filename":"nagatomo200912.pdf","filesize":[{"value":"1.0 MB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"nagatomo200912.pdf","url":"https://miyazaki-u.repo.nii.ac.jp/record/1532.1/files/nagatomo200912.pdf"},"version_id":"adc0cce4-a920-4c2c-a2f9-583889ac1ecc"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"risperidone, orally disintegrating tablets, questionnaire survey, schizophrenia, adherence","subitem_subject_language":"en","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"Risperidone錠からrisperidone口腔内崩壊錠への切り替え後の患者を対象に行ったアンケート調査","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Risperidone錠からrisperidone口腔内崩壊錠への切り替え後の患者を対象に行ったアンケート調査","subitem_title_language":"ja"}]},"item_type_id":"10001","owner":"2","path":["30"],"pubdate":{"attribute_name":"公開日","attribute_value":"2010-01-08"},"publish_date":"2010-01-08","publish_status":"0","recid":"1532.1","relation_version_is_last":true,"title":["Risperidone錠からrisperidone口腔内崩壊錠への切り替え後の患者を対象に行ったアンケート調査"],"weko_creator_id":"2","weko_shared_id":2},"updated":"2023-07-24T04:59:16.161088+00:00"}